Company Search:
Advanced Search
Sponsored Links
Avexa Ltd Company Snapshot
Avexa Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avexa Ltd with three other companies in this sector in Australia: Novogen Limited (2016 sales of 405,701.00 Australian Dollars [US$301,861.83 ] ), Actinogen Medical Ltd (204,491.00 Australian Dollars [US$152,151.53 ] ), and Ephraim Resources Ltd (219,242.00 Australian Dollars [US$163,127.01 ] ).

Sales Analysis. During the year ended June of 2016, sales at Avexa Ltd were A$303,374.00 (US$225.73 thousand). This is a decrease of 4.9% versus 2015, when the company's sales were A$319,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Avexa Ltd
  Stock Performance Chart for Avexa Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): .03
(Figures in Australian Dollars)
1 Week 18.5%   13 Weeks 28.0%  
4 Weeks 3.2%   52 Weeks -19.3%  
Avexa Ltd Key Data:
  Ticker: NHL Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 303,374
(Year Ending Jan 2017).
Employees: 5
  Currency: Australian Dollars Market Cap: 3,809,780
  Fiscal Yr Ends: June Shares Outstanding: 119,055,615
  Share Type: ORDINARY Closely Held Shares: 31,381,542
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.